New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
New Delhi [India], January 5 (ANI): With Drugs Controller General of India (DCGI) approving two vaccine candidates in India, the Kazakhstan Ambassador to India Yerlan Alimbayev said that Kazakhstan will discuss the matter with India and is ready to procure the vaccines.
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
New Delhi [India], January 4 (ANI): After the drug regulator of the country gave in principle approval for restricted emergency use to two indigenously made vaccines, Bharatiya Janata Party (BJP) spokesperson Sambit Patra on Monday said that when India's scientists develop things for public
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
New Delhi [India], January 4 (ANI): A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and manifestation
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains
New Delhi [India], January 3 (ANI): An Memorandum of Understanding (MoU) has been signed between Government of India, State Government and Food Cooperation of India in both Scheme of Decentralised procurement (DCP) and non-DCP states for procurement of paddy from farmers under the central po
New Delhi [India], January 3 (ANI): India reported 18,177 new COVID-19 cases in the last 24 hours, taking the total number of coronavirus cases in the country to 1,03,23,965, the Union Ministry of Health and Family Welfare (MoHFW) informed on Sunday.